1,678 institutions reported holding Vertex Pharma as of 2026-03-31, totalling $103.6B. Sourced from SEC Form 13F filings, filed up to 45 days after quarter end.
#
Institution
Value
1
Capital World Investors
$11.3B
2
BlackRock, Inc.
$10.7B
3
Capital Research Global Investors
$9.4B
4
VANGUARD CAPITAL MANAGEMENT LLC
$7.4B
5
STATE STREET CORP
$5.2B
Source: SEC Form 13F filings via SEC EDGAR. Covers long US-listed equity only — short positions, bonds and non-US holdings are not reported on this form.